DOI: 10.1128/JCM.01843-16
Article Information
PubMed
Published By
History
- Received September 18, 2016
- Returned for modification September 30, 2016
- Accepted October 25, 2016
- Published online December 28, 2016.
Copyright & Usage
Copyright © 2016 American Society for Microbiology.
All Rights Reserved
.
Editors and / or Reviewers
- Robin Patel, Editor, Mayo Clinic
Article Versions
- Accepted Manuscript version (November 02, 2016).
- You are viewing the most recent version of this article.
Author Information
- Chloé Duponta,
- Estelle Jumas-Bilaka,b,
- Anne-Laure Michona,c,
- Raphaël Chirond and
- Hélène Marchandina,c
- aUniversité Montpellier, UMR5569 Hydrosciences Montpellier, Equipe Pathogènes Hydriques, Santé, Environnements, UFR des Sciences Pharmaceutiques et Biologiques, Montpellier, France
- bCentre Hospitalier Régional Universitaire de Montpellier, Hôpital Saint-Eloi, Laboratoire d'Hygiène hospitalière, Montpellier, France
- cCentre Hospitalier Régional Universitaire de Montpellier, Hôpital Arnaud de Villeneuve, Laboratoire de Bactériologie, Montpellier, France
- dCentre Hospitalier Régional Universitaire de Montpellier, Hôpital Arnaud de Villeneuve, Centre de Ressources et de Compétences pour la Mucoviscidose, Montpellier, France
- Address correspondence to Hélène Marchandin, helene.marchandin{at}umontpellier.fr.
Citation Dupont C, Jumas-Bilak E, Michon A-L, Chiron R, Marchandin H. 2017. Impact of high diversity of Achromobacter populations within cystic fibrosis sputum samples on antimicrobial susceptibility testing. J Clin Microbiol 55:206–215. https://doi.org/10.1128/JCM.01843-16 .
